| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 56 | 2024 | 36743 | 1.130 |
Why?
|
| Hearing Loss, Sensorineural | 8 | 2024 | 783 | 1.120 |
Why?
|
| Branchio-Oto-Renal Syndrome | 3 | 2022 | 25 | 1.110 |
Why?
|
| Temporal Bone | 8 | 2024 | 683 | 1.010 |
Why?
|
| Neck | 7 | 2024 | 736 | 1.000 |
Why?
|
| Prenatal Diagnosis | 7 | 2024 | 1275 | 0.950 |
Why?
|
| Deafness | 2 | 2023 | 460 | 0.910 |
Why?
|
| Head | 5 | 2024 | 926 | 0.850 |
Why?
|
| Hearing Loss, Conductive | 2 | 2023 | 159 | 0.840 |
Why?
|
| Head and Neck Neoplasms | 13 | 2024 | 2931 | 0.810 |
Why?
|
| Craniofacial Abnormalities | 7 | 2015 | 320 | 0.760 |
Why?
|
| Optic Disk | 2 | 2024 | 421 | 0.760 |
Why?
|
| Tomography, X-Ray Computed | 36 | 2024 | 20760 | 0.760 |
Why?
|
| Nose | 3 | 2015 | 522 | 0.730 |
Why?
|
| Ophthalmoplegia | 5 | 2021 | 168 | 0.670 |
Why?
|
| Nose Neoplasms | 6 | 2018 | 250 | 0.650 |
Why?
|
| Abnormalities, Multiple | 7 | 2021 | 1424 | 0.630 |
Why?
|
| Cysts | 5 | 2018 | 685 | 0.620 |
Why?
|
| Hydrocephalus | 3 | 2016 | 768 | 0.610 |
Why?
|
| Nose Diseases | 2 | 2016 | 78 | 0.570 |
Why?
|
| Bone Diseases | 3 | 2015 | 416 | 0.560 |
Why?
|
| Diagnostic Imaging | 8 | 2017 | 3533 | 0.550 |
Why?
|
| Fibromatosis, Aggressive | 3 | 2023 | 125 | 0.520 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2016 | 16 | 0.520 |
Why?
|
| Facial Paralysis | 4 | 2023 | 346 | 0.520 |
Why?
|
| Child | 80 | 2024 | 80917 | 0.510 |
Why?
|
| Child, Preschool | 64 | 2024 | 42669 | 0.480 |
Why?
|
| Laryngeal Neoplasms | 4 | 2018 | 514 | 0.460 |
Why?
|
| Orbit | 4 | 2015 | 459 | 0.450 |
Why?
|
| Ear, Inner | 3 | 2023 | 426 | 0.440 |
Why?
|
| Respiratory System Abnormalities | 1 | 2014 | 67 | 0.440 |
Why?
|
| Tubulin | 3 | 2021 | 695 | 0.410 |
Why?
|
| Infant | 51 | 2024 | 36535 | 0.410 |
Why?
|
| CHARGE Syndrome | 2 | 2023 | 34 | 0.400 |
Why?
|
| Cerebral Ventricles | 6 | 2012 | 550 | 0.390 |
Why?
|
| Eye Diseases | 2 | 2015 | 660 | 0.380 |
Why?
|
| Connexins | 2 | 2011 | 355 | 0.380 |
Why?
|
| Ultrasonography, Prenatal | 9 | 2012 | 1772 | 0.380 |
Why?
|
| Hearing Loss | 4 | 2023 | 785 | 0.370 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2011 | 13 | 0.370 |
Why?
|
| Conjunctival Diseases | 1 | 2012 | 109 | 0.370 |
Why?
|
| Cochlea | 5 | 2023 | 848 | 0.370 |
Why?
|
| Craniosynostoses | 6 | 2017 | 415 | 0.360 |
Why?
|
| Lymphadenitis | 3 | 2000 | 99 | 0.360 |
Why?
|
| Fibrosis | 4 | 2021 | 2080 | 0.350 |
Why?
|
| Eyelid Diseases | 1 | 2012 | 155 | 0.340 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2021 | 716 | 0.340 |
Why?
|
| Muscular Atrophy | 2 | 2023 | 335 | 0.310 |
Why?
|
| Syndrome | 6 | 2023 | 3272 | 0.300 |
Why?
|
| Eye Abnormalities | 2 | 2024 | 243 | 0.300 |
Why?
|
| Dermoid Cyst | 4 | 2016 | 92 | 0.300 |
Why?
|
| Teratoma | 4 | 2013 | 405 | 0.300 |
Why?
|
| Mandibular Neoplasms | 2 | 2023 | 131 | 0.300 |
Why?
|
| Choristoma | 3 | 2016 | 205 | 0.290 |
Why?
|
| Rhabdomyosarcoma | 2 | 2021 | 358 | 0.290 |
Why?
|
| Humans | 139 | 2024 | 768166 | 0.280 |
Why?
|
| Salivary Gland Neoplasms | 3 | 2019 | 306 | 0.270 |
Why?
|
| Sphenoid Bone | 2 | 2024 | 176 | 0.270 |
Why?
|
| Fetal Diseases | 3 | 2011 | 916 | 0.270 |
Why?
|
| Patient Care Team | 1 | 2017 | 2523 | 0.270 |
Why?
|
| Image Enhancement | 5 | 2008 | 2880 | 0.260 |
Why?
|
| Translocation, Genetic | 2 | 2009 | 1394 | 0.260 |
Why?
|
| Craniofacial Dysostosis | 3 | 2015 | 74 | 0.260 |
Why?
|
| Encephalocele | 3 | 2016 | 135 | 0.250 |
Why?
|
| Brain Diseases | 7 | 2020 | 1554 | 0.240 |
Why?
|
| Osteomyelitis | 2 | 2021 | 408 | 0.240 |
Why?
|
| Mutation | 16 | 2024 | 30238 | 0.240 |
Why?
|
| Adolescent | 51 | 2024 | 89169 | 0.240 |
Why?
|
| Female | 93 | 2024 | 397192 | 0.240 |
Why?
|
| Male | 92 | 2024 | 364719 | 0.240 |
Why?
|
| Otorhinolaryngologic Diseases | 2 | 2010 | 97 | 0.240 |
Why?
|
| Mouth Abnormalities | 1 | 2004 | 19 | 0.230 |
Why?
|
| Nasal Cavity | 2 | 2018 | 310 | 0.230 |
Why?
|
| Dissent and Disputes | 2 | 2022 | 150 | 0.230 |
Why?
|
| Infant, Newborn | 27 | 2024 | 26422 | 0.230 |
Why?
|
| Skull Base | 4 | 2021 | 294 | 0.230 |
Why?
|
| Optic Chiasm | 1 | 2024 | 91 | 0.230 |
Why?
|
| Retrospective Studies | 38 | 2024 | 81762 | 0.230 |
Why?
|
| Acrocephalosyndactylia | 3 | 2015 | 93 | 0.220 |
Why?
|
| Nasopharyngeal Neoplasms | 2 | 2003 | 290 | 0.220 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2024 | 87 | 0.220 |
Why?
|
| Oculomotor Muscles | 2 | 2019 | 405 | 0.220 |
Why?
|
| Optic Atrophy | 2 | 2014 | 79 | 0.220 |
Why?
|
| Brain Damage, Chronic | 2 | 2002 | 265 | 0.220 |
Why?
|
| Adenoma, Pleomorphic | 2 | 2018 | 77 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2022 | 458 | 0.220 |
Why?
|
| DNA Mutational Analysis | 2 | 2014 | 4120 | 0.220 |
Why?
|
| Vestibular Aqueduct | 1 | 2024 | 73 | 0.210 |
Why?
|
| Carcinoma, Mucoepidermoid | 2 | 2019 | 91 | 0.210 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2004 | 148 | 0.210 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2019 | 354 | 0.210 |
Why?
|
| Myxoma | 1 | 2023 | 114 | 0.210 |
Why?
|
| Ear, Middle | 2 | 2023 | 341 | 0.200 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2023 | 116 | 0.200 |
Why?
|
| Hypoxia, Brain | 2 | 2002 | 139 | 0.190 |
Why?
|
| Mutation, Missense | 3 | 2024 | 2592 | 0.190 |
Why?
|
| Hematoma, Subdural | 2 | 2000 | 128 | 0.190 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2023 | 219 | 0.190 |
Why?
|
| Neurocutaneous Syndromes | 2 | 2015 | 53 | 0.190 |
Why?
|
| Cerebral Infarction | 4 | 2003 | 969 | 0.180 |
Why?
|
| Alleles | 2 | 2018 | 6894 | 0.180 |
Why?
|
| Walker-Warburg Syndrome | 1 | 2020 | 15 | 0.180 |
Why?
|
| Homeodomain Proteins | 3 | 2022 | 2429 | 0.180 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 2000 | 20 | 0.180 |
Why?
|
| Child Abuse | 2 | 2000 | 1091 | 0.180 |
Why?
|
| Phenotype | 11 | 2024 | 16726 | 0.180 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2020 | 85 | 0.170 |
Why?
|
| Cerebral Veins | 2 | 2017 | 157 | 0.170 |
Why?
|
| Parotid Neoplasms | 3 | 2007 | 158 | 0.170 |
Why?
|
| Cochlear Implantation | 1 | 2024 | 317 | 0.170 |
Why?
|
| Mobius Syndrome | 2 | 2017 | 41 | 0.170 |
Why?
|
| Tenotomy | 1 | 2019 | 53 | 0.170 |
Why?
|
| Corpus Callosum | 2 | 2019 | 753 | 0.160 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 4978 | 0.160 |
Why?
|
| Diagnosis, Differential | 12 | 2024 | 13014 | 0.160 |
Why?
|
| Radiology | 2 | 2023 | 2104 | 0.160 |
Why?
|
| Mycobacterium Infections | 1 | 1999 | 122 | 0.160 |
Why?
|
| Tomography, X-Ray | 1 | 2018 | 58 | 0.160 |
Why?
|
| Malformations of Cortical Development | 1 | 2021 | 176 | 0.160 |
Why?
|
| Lip Neoplasms | 1 | 2018 | 36 | 0.160 |
Why?
|
| Valine | 1 | 2020 | 410 | 0.160 |
Why?
|
| Vestibular Diseases | 1 | 2021 | 232 | 0.150 |
Why?
|
| Cranial Sutures | 2 | 2017 | 92 | 0.150 |
Why?
|
| Myogenic Regulatory Factor 5 | 1 | 2018 | 27 | 0.150 |
Why?
|
| Free Tissue Flaps | 1 | 2023 | 335 | 0.150 |
Why?
|
| Granuloma | 1 | 2000 | 329 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2003 | 597 | 0.150 |
Why?
|
| Adipose Tissue | 2 | 2009 | 3329 | 0.150 |
Why?
|
| Video Games | 1 | 2020 | 202 | 0.150 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2003 | 493 | 0.140 |
Why?
|
| Ultrasonography | 3 | 2018 | 6004 | 0.140 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2021 | 528 | 0.140 |
Why?
|
| Pyramidal Tracts | 1 | 2019 | 251 | 0.140 |
Why?
|
| Hematologic Diseases | 1 | 2021 | 498 | 0.140 |
Why?
|
| Nuclear Proteins | 3 | 2022 | 5804 | 0.140 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 325 | 0.140 |
Why?
|
| Ear Diseases | 1 | 1999 | 181 | 0.140 |
Why?
|
| Pineal Gland | 1 | 1997 | 158 | 0.130 |
Why?
|
| MafB Transcription Factor | 1 | 2016 | 25 | 0.130 |
Why?
|
| Ribs | 1 | 2018 | 259 | 0.130 |
Why?
|
| Eye Diseases, Hereditary | 2 | 2015 | 124 | 0.130 |
Why?
|
| Genotype | 1 | 2011 | 13045 | 0.130 |
Why?
|
| Eye Movements | 1 | 2019 | 514 | 0.130 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2020 | 616 | 0.130 |
Why?
|
| Myoblasts | 1 | 2017 | 234 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2009 | 4058 | 0.130 |
Why?
|
| Medical Informatics Applications | 1 | 2017 | 180 | 0.130 |
Why?
|
| Skull | 2 | 2017 | 820 | 0.130 |
Why?
|
| Duane Retraction Syndrome | 1 | 2016 | 59 | 0.130 |
Why?
|
| Mandibular Diseases | 1 | 2016 | 117 | 0.120 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2016 | 197 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2892 | 0.120 |
Why?
|
| Ventriculostomy | 1 | 2016 | 132 | 0.120 |
Why?
|
| Xerostomia | 1 | 2015 | 94 | 0.120 |
Why?
|
| Tendons | 1 | 2019 | 556 | 0.120 |
Why?
|
| Pierre Robin Syndrome | 1 | 2017 | 118 | 0.120 |
Why?
|
| Radiation Protection | 2 | 2017 | 428 | 0.120 |
Why?
|
| Blood-Brain Barrier | 1 | 2002 | 1034 | 0.120 |
Why?
|
| Face | 1 | 2021 | 1029 | 0.120 |
Why?
|
| Laryngeal Diseases | 1 | 2018 | 248 | 0.120 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2016 | 121 | 0.120 |
Why?
|
| Pregnancy | 12 | 2024 | 30256 | 0.120 |
Why?
|
| Echoencephalography | 2 | 2009 | 134 | 0.120 |
Why?
|
| Labyrinth Diseases | 1 | 2016 | 151 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2020 | 9419 | 0.120 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2015 | 72 | 0.120 |
Why?
|
| Spine | 2 | 2020 | 1140 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2021 | 617 | 0.120 |
Why?
|
| Loss of Heterozygosity | 1 | 2017 | 663 | 0.120 |
Why?
|
| Behavior Therapy | 1 | 2020 | 886 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2024 | 1901 | 0.120 |
Why?
|
| Mandible | 2 | 2023 | 754 | 0.110 |
Why?
|
| Salivary Glands | 1 | 2015 | 231 | 0.110 |
Why?
|
| Developmental Disabilities | 4 | 2015 | 1518 | 0.110 |
Why?
|
| Peptide Termination Factors | 1 | 2014 | 56 | 0.110 |
Why?
|
| Language | 1 | 2023 | 1557 | 0.110 |
Why?
|
| Retropharyngeal Abscess | 1 | 2013 | 21 | 0.110 |
Why?
|
| Dura Mater | 2 | 2017 | 293 | 0.110 |
Why?
|
| Lacrimal Apparatus | 1 | 2015 | 224 | 0.110 |
Why?
|
| Morphogenesis | 1 | 2017 | 746 | 0.110 |
Why?
|
| Papilledema | 1 | 2014 | 130 | 0.110 |
Why?
|
| Facial Asymmetry | 2 | 2007 | 173 | 0.110 |
Why?
|
| Muscle Neoplasms | 1 | 2014 | 130 | 0.110 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 278 | 0.110 |
Why?
|
| Craniopharyngioma | 1 | 1996 | 279 | 0.100 |
Why?
|
| Leigh Disease | 1 | 2014 | 89 | 0.100 |
Why?
|
| Muscular Diseases | 1 | 2017 | 553 | 0.100 |
Why?
|
| Malleus | 1 | 2012 | 27 | 0.100 |
Why?
|
| Drainage | 2 | 2013 | 1183 | 0.100 |
Why?
|
| Brain Neoplasms | 6 | 2014 | 9118 | 0.100 |
Why?
|
| Hepatitis B Antibodies | 1 | 2013 | 156 | 0.100 |
Why?
|
| Neurofibroma | 2 | 2004 | 95 | 0.100 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2017 | 845 | 0.100 |
Why?
|
| Hepatitis B Vaccines | 1 | 2013 | 178 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2017 | 1165 | 0.100 |
Why?
|
| Fundus Oculi | 1 | 2013 | 560 | 0.090 |
Why?
|
| Brain Injuries | 2 | 2000 | 2057 | 0.090 |
Why?
|
| Nerve Fibers | 1 | 2014 | 709 | 0.090 |
Why?
|
| Ear Neoplasms | 1 | 2011 | 118 | 0.090 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 1019 | 0.090 |
Why?
|
| Septum Pellucidum | 1 | 2011 | 55 | 0.090 |
Why?
|
| Petrous Bone | 1 | 2011 | 85 | 0.090 |
Why?
|
| Bronchogenic Cyst | 1 | 2010 | 28 | 0.090 |
Why?
|
| Neoplasms, Second Primary | 1 | 2018 | 1061 | 0.090 |
Why?
|
| Observer Variation | 4 | 2010 | 2622 | 0.090 |
Why?
|
| Optic Nerve Diseases | 2 | 2013 | 342 | 0.090 |
Why?
|
| Epilepsy | 1 | 2006 | 3327 | 0.090 |
Why?
|
| Pregnancy Outcome | 5 | 2012 | 2972 | 0.090 |
Why?
|
| Osteotomy, Le Fort | 1 | 2011 | 94 | 0.090 |
Why?
|
| Young Adult | 14 | 2023 | 60066 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2020 | 2697 | 0.090 |
Why?
|
| Neuroglia | 1 | 2016 | 960 | 0.080 |
Why?
|
| Immunoglobulins | 1 | 2013 | 855 | 0.080 |
Why?
|
| Tooth Migration | 1 | 2009 | 11 | 0.080 |
Why?
|
| Goiter | 1 | 2010 | 86 | 0.080 |
Why?
|
| Siblings | 1 | 2014 | 828 | 0.080 |
Why?
|
| Dentigerous Cyst | 1 | 2009 | 18 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2023 | 9615 | 0.080 |
Why?
|
| Epiglottis | 1 | 2009 | 81 | 0.080 |
Why?
|
| Optic Nerve | 1 | 2013 | 571 | 0.080 |
Why?
|
| Digestive System | 1 | 2010 | 244 | 0.080 |
Why?
|
| Gestational Age | 4 | 2011 | 3621 | 0.080 |
Why?
|
| Semicircular Canals | 1 | 2011 | 203 | 0.080 |
Why?
|
| Maxillary Sinusitis | 1 | 2009 | 41 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3603 | 0.080 |
Why?
|
| Cochlear Nerve | 1 | 2011 | 202 | 0.080 |
Why?
|
| Lingual Thyroid | 1 | 2008 | 7 | 0.080 |
Why?
|
| Retinal Ganglion Cells | 1 | 2014 | 811 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 350 | 0.080 |
Why?
|
| Osteogenesis, Distraction | 1 | 2011 | 233 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2009 | 361 | 0.070 |
Why?
|
| Glottis | 1 | 2009 | 214 | 0.070 |
Why?
|
| Follow-Up Studies | 12 | 2020 | 39348 | 0.070 |
Why?
|
| Strabismus | 1 | 2012 | 320 | 0.070 |
Why?
|
| Blood Vessels | 2 | 2007 | 1110 | 0.070 |
Why?
|
| Vertigo | 2 | 2007 | 205 | 0.070 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2008 | 134 | 0.070 |
Why?
|
| Adult | 25 | 2024 | 223646 | 0.070 |
Why?
|
| Hepatitis B | 1 | 2013 | 711 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2011 | 6229 | 0.070 |
Why?
|
| Nevus, Pigmented | 1 | 2009 | 222 | 0.070 |
Why?
|
| Diffusion | 4 | 2002 | 815 | 0.070 |
Why?
|
| Pituitary Neoplasms | 1 | 1996 | 1322 | 0.070 |
Why?
|
| Zygoma | 1 | 2007 | 52 | 0.070 |
Why?
|
| Central Nervous System Diseases | 2 | 2008 | 520 | 0.070 |
Why?
|
| Lipomatosis | 1 | 2007 | 112 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 3390 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 5812 | 0.070 |
Why?
|
| DNA Helicases | 2 | 2023 | 854 | 0.070 |
Why?
|
| Orbital Diseases | 2 | 2001 | 178 | 0.070 |
Why?
|
| Night Terrors | 1 | 2006 | 1 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2016 | 1294 | 0.070 |
Why?
|
| Palate, Soft | 1 | 2006 | 100 | 0.070 |
Why?
|
| Pedigree | 4 | 2017 | 4539 | 0.070 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2007 | 115 | 0.070 |
Why?
|
| Factitious Disorders | 1 | 2006 | 39 | 0.060 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2013 | 1354 | 0.060 |
Why?
|
| Fantasy | 1 | 2006 | 69 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3610 | 0.060 |
Why?
|
| Patient Selection | 1 | 2017 | 4260 | 0.060 |
Why?
|
| Cockayne Syndrome | 1 | 2005 | 20 | 0.060 |
Why?
|
| Long QT Syndrome | 1 | 2010 | 472 | 0.060 |
Why?
|
| Ethmoid Bone | 1 | 2005 | 35 | 0.060 |
Why?
|
| Basilar Membrane | 1 | 2005 | 50 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2006 | 212 | 0.060 |
Why?
|
| Prospective Studies | 10 | 2019 | 54926 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 3 | 2016 | 7454 | 0.060 |
Why?
|
| Twins, Dizygotic | 1 | 2005 | 236 | 0.060 |
Why?
|
| Goiter, Nodular | 1 | 2024 | 28 | 0.060 |
Why?
|
| Choroid Plexus | 1 | 2007 | 249 | 0.060 |
Why?
|
| Stem Cells | 1 | 2017 | 3537 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2357 | 0.060 |
Why?
|
| Brain | 7 | 2020 | 27360 | 0.060 |
Why?
|
| Moyamoya Disease | 2 | 1998 | 274 | 0.060 |
Why?
|
| Craniotomy | 2 | 2000 | 736 | 0.060 |
Why?
|
| Arteriovenous Fistula | 1 | 2007 | 320 | 0.060 |
Why?
|
| Decision Making | 1 | 2017 | 3953 | 0.060 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2006 | 392 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 18065 | 0.050 |
Why?
|
| Child Development | 2 | 2010 | 2330 | 0.050 |
Why?
|
| Dexmedetomidine | 1 | 2008 | 320 | 0.050 |
Why?
|
| Conscious Sedation | 1 | 2008 | 534 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2018 | 2179 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2019 | 1791 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 2521 | 0.050 |
Why?
|
| Heterozygote | 2 | 2021 | 2798 | 0.050 |
Why?
|
| Fatal Outcome | 3 | 2007 | 1836 | 0.050 |
Why?
|
| Neurons, Efferent | 1 | 2023 | 81 | 0.050 |
Why?
|
| Thyroglossal Cyst | 1 | 2003 | 31 | 0.050 |
Why?
|
| Syncope | 1 | 2006 | 430 | 0.050 |
Why?
|
| GATA2 Transcription Factor | 1 | 2023 | 158 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5717 | 0.050 |
Why?
|
| Meningitis, Bacterial | 1 | 2005 | 225 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2023 | 182 | 0.050 |
Why?
|
| Radiography | 4 | 2009 | 6983 | 0.050 |
Why?
|
| Vascular Neoplasms | 1 | 2004 | 167 | 0.050 |
Why?
|
| Cerebral Angiography | 2 | 1998 | 1264 | 0.050 |
Why?
|
| Movement Disorders | 1 | 2006 | 463 | 0.050 |
Why?
|
| Sarcoma | 1 | 2013 | 1806 | 0.050 |
Why?
|
| Endoscopy | 4 | 2016 | 1854 | 0.050 |
Why?
|
| Cocaine-Related Disorders | 2 | 2008 | 458 | 0.050 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2003 | 243 | 0.050 |
Why?
|
| Tomography, Optical Coherence | 1 | 2014 | 2957 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2007 | 1120 | 0.050 |
Why?
|
| Fetus | 2 | 2006 | 1883 | 0.050 |
Why?
|
| Astrocytoma | 2 | 2003 | 774 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2016 | 15832 | 0.050 |
Why?
|
| Trismus | 1 | 2020 | 33 | 0.050 |
Why?
|
| Cranial Nerves | 1 | 2021 | 97 | 0.050 |
Why?
|
| Dystroglycans | 1 | 2020 | 62 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2024 | 65371 | 0.050 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2000 | 25 | 0.050 |
Why?
|
| Histidine | 1 | 2021 | 301 | 0.050 |
Why?
|
| Cat-Scratch Disease | 1 | 2000 | 23 | 0.040 |
Why?
|
| Maternal Exposure | 1 | 2008 | 1096 | 0.040 |
Why?
|
| Tuberculosis, Lymph Node | 1 | 2000 | 21 | 0.040 |
Why?
|
| Tularemia | 1 | 2000 | 40 | 0.040 |
Why?
|
| Histoplasmosis | 1 | 2000 | 63 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2017 | 7876 | 0.040 |
Why?
|
| Models, Anatomic | 1 | 2024 | 680 | 0.040 |
Why?
|
| Pneumococcal Infections | 1 | 2005 | 529 | 0.040 |
Why?
|
| Mesoderm | 2 | 2017 | 679 | 0.040 |
Why?
|
| DNA | 1 | 2014 | 7214 | 0.040 |
Why?
|
| Sinusitis | 1 | 2009 | 997 | 0.040 |
Why?
|
| Submandibular Gland Diseases | 1 | 1999 | 22 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2000 | 194 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2008 | 1191 | 0.040 |
Why?
|
| Submandibular Gland | 1 | 1999 | 85 | 0.040 |
Why?
|
| Cervical Vertebrae | 2 | 2023 | 979 | 0.040 |
Why?
|
| North America | 1 | 2023 | 1289 | 0.040 |
Why?
|
| Parotid Diseases | 1 | 1999 | 49 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 1999 | 7951 | 0.040 |
Why?
|
| Neurofibromatosis 1 | 2 | 2004 | 561 | 0.040 |
Why?
|
| Retinal Hemorrhage | 1 | 2000 | 98 | 0.040 |
Why?
|
| Skin Diseases | 1 | 2007 | 1085 | 0.040 |
Why?
|
| Hemangioma | 2 | 2007 | 727 | 0.040 |
Why?
|
| Age Factors | 3 | 2020 | 18412 | 0.040 |
Why?
|
| Airway Obstruction | 2 | 2018 | 672 | 0.040 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2000 | 169 | 0.040 |
Why?
|
| Prognosis | 7 | 2020 | 30010 | 0.040 |
Why?
|
| Parotid Gland | 1 | 1999 | 178 | 0.040 |
Why?
|
| Asphyxia Neonatorum | 1 | 1999 | 111 | 0.040 |
Why?
|
| Vascular Malformations | 1 | 2024 | 469 | 0.040 |
Why?
|
| Hearing Disorders | 1 | 1999 | 126 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 1281 | 0.040 |
Why?
|
| Histone Demethylases | 1 | 2021 | 328 | 0.040 |
Why?
|
| Kallmann Syndrome | 1 | 2019 | 142 | 0.040 |
Why?
|
| Skull Fractures | 1 | 2000 | 203 | 0.040 |
Why?
|
| Laryngomalacia | 1 | 2018 | 32 | 0.040 |
Why?
|
| beta Catenin | 1 | 2023 | 1047 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2023 | 870 | 0.040 |
Why?
|
| Bone Transplantation | 1 | 2023 | 925 | 0.040 |
Why?
|
| MyoD Protein | 1 | 2018 | 143 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2023 | 724 | 0.040 |
Why?
|
| Arginine | 1 | 2021 | 932 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2024 | 1778 | 0.040 |
Why?
|
| Transverse Sinuses | 1 | 2017 | 25 | 0.040 |
Why?
|
| Endophenotypes | 1 | 2019 | 259 | 0.040 |
Why?
|
| Limb Deformities, Congenital | 1 | 2018 | 136 | 0.040 |
Why?
|
| Abscess | 1 | 2001 | 606 | 0.040 |
Why?
|
| United States | 3 | 2022 | 73039 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2007 | 2589 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 1743 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6974 | 0.030 |
Why?
|
| Pia Mater | 1 | 1997 | 85 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2017 | 294 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2023 | 864 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2017 | 557 | 0.030 |
Why?
|
| Brain Death | 1 | 2000 | 359 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 14729 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2018 | 565 | 0.030 |
Why?
|
| Acute Disease | 3 | 2007 | 7243 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 13421 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2002 | 952 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2862 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 7477 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2017 | 278 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 1885 | 0.030 |
Why?
|
| Anisotropy | 1 | 2019 | 1292 | 0.030 |
Why?
|
| Safety | 1 | 2020 | 1159 | 0.030 |
Why?
|
| Anal Canal | 1 | 2018 | 376 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 1082 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2017 | 23645 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 2538 | 0.030 |
Why?
|
| Spinal Diseases | 1 | 2020 | 561 | 0.030 |
Why?
|
| Mice | 5 | 2024 | 82029 | 0.030 |
Why?
|
| Migraine Disorders | 2 | 2006 | 1713 | 0.030 |
Why?
|
| Neurilemmoma | 1 | 2000 | 522 | 0.030 |
Why?
|
| Neural Crest | 1 | 2017 | 278 | 0.030 |
Why?
|
| Cerebral Arteries | 1 | 2017 | 488 | 0.030 |
Why?
|
| Educational Status | 1 | 2022 | 2515 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2024 | 2258 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 2000 | 535 | 0.030 |
Why?
|
| Animals | 7 | 2024 | 169246 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2017 | 625 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2020 | 6847 | 0.030 |
Why?
|
| Boston | 3 | 2008 | 9374 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 1754 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 2267 | 0.030 |
Why?
|
| Calcinosis | 1 | 2003 | 1481 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 2433 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2018 | 702 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 1999 | 810 | 0.030 |
Why?
|
| Child Health Services | 1 | 1999 | 645 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2017 | 910 | 0.030 |
Why?
|
| Orbital Neoplasms | 1 | 1996 | 223 | 0.030 |
Why?
|
| Uvea | 1 | 2013 | 31 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2003 | 1876 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2015 | 243 | 0.030 |
Why?
|
| Subarachnoid Space | 1 | 2013 | 79 | 0.030 |
Why?
|
| London | 1 | 2013 | 233 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 2748 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2006 | 3620 | 0.030 |
Why?
|
| Scalp | 1 | 1996 | 391 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1995 | 777 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3728 | 0.030 |
Why?
|
| Piperazines | 1 | 2003 | 2554 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2024 | 3445 | 0.030 |
Why?
|
| Intracranial Pressure | 1 | 2014 | 323 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2022 | 2744 | 0.030 |
Why?
|
| Radiation Dosage | 2 | 2016 | 1967 | 0.020 |
Why?
|
| Exons | 1 | 2018 | 2394 | 0.020 |
Why?
|
| Binding Sites | 1 | 2021 | 6020 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2014 | 963 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2000 | 1811 | 0.020 |
Why?
|
| Esophagus | 1 | 2018 | 1042 | 0.020 |
Why?
|
| Consensus | 1 | 2022 | 3212 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2000 | 1266 | 0.020 |
Why?
|
| Trachea | 1 | 2018 | 1095 | 0.020 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2013 | 294 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2017 | 1145 | 0.020 |
Why?
|
| Founder Effect | 1 | 2012 | 185 | 0.020 |
Why?
|
| Sclera | 1 | 2013 | 189 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14488 | 0.020 |
Why?
|
| Audiometry | 1 | 2012 | 253 | 0.020 |
Why?
|
| Thyroid Neoplasms | 1 | 2005 | 2360 | 0.020 |
Why?
|
| Visual Pathways | 1 | 1996 | 557 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2000 | 1164 | 0.020 |
Why?
|
| Neurons | 2 | 2024 | 9514 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 4423 | 0.020 |
Why?
|
| Genome, Human | 1 | 2024 | 4446 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 20227 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 3780 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 1999 | 3474 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2003 | 3048 | 0.020 |
Why?
|
| Serologic Tests | 1 | 2013 | 382 | 0.020 |
Why?
|
| Tunisia | 1 | 2010 | 36 | 0.020 |
Why?
|
| Immunization Programs | 1 | 2013 | 267 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 1676 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 3556 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2008 | 24315 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2007 | 9015 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2017 | 1346 | 0.020 |
Why?
|
| Laser Therapy | 2 | 2008 | 1107 | 0.020 |
Why?
|
| Middle Aged | 6 | 2024 | 223492 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 15454 | 0.020 |
Why?
|
| Down Syndrome | 1 | 1997 | 919 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 2420 | 0.020 |
Why?
|
| Glioma | 1 | 2003 | 3503 | 0.020 |
Why?
|
| Vision Disorders | 1 | 1996 | 1093 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2010 | 527 | 0.020 |
Why?
|
| Glossectomy | 1 | 2008 | 60 | 0.020 |
Why?
|
| Kidney | 2 | 2018 | 7064 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2019 | 3117 | 0.020 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2008 | 58 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 979 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2010 | 301 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 41754 | 0.020 |
Why?
|
| Cerebellum | 1 | 2015 | 1522 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2536 | 0.020 |
Why?
|
| Visual Fields | 1 | 2014 | 1065 | 0.020 |
Why?
|
| Pentobarbital | 1 | 2008 | 153 | 0.020 |
Why?
|
| Cerebral Aqueduct | 1 | 2007 | 39 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 2819 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2815 | 0.020 |
Why?
|
| Thyroid Function Tests | 1 | 2008 | 289 | 0.020 |
Why?
|
| Anesthesia Recovery Period | 1 | 2008 | 155 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2010 | 659 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2019 | 22291 | 0.020 |
Why?
|
| Lateral Ventricles | 1 | 2007 | 142 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 2565 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2007 | 244 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2007 | 313 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 7140 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 1750 | 0.020 |
Why?
|
| Bradycardia | 1 | 2008 | 305 | 0.020 |
Why?
|
| Melanosis | 1 | 2007 | 93 | 0.020 |
Why?
|
| Epithelium | 1 | 2010 | 1607 | 0.020 |
Why?
|
| Zebrafish | 1 | 2017 | 3035 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 1999 | 2973 | 0.020 |
Why?
|
| Echo-Planar Imaging | 2 | 2000 | 648 | 0.020 |
Why?
|
| Occipital Bone | 1 | 2005 | 55 | 0.020 |
Why?
|
| Case Management | 1 | 2007 | 277 | 0.020 |
Why?
|
| Parietal Bone | 1 | 2005 | 49 | 0.020 |
Why?
|
| Tongue | 1 | 2008 | 406 | 0.020 |
Why?
|
| Pharyngectomy | 1 | 2004 | 45 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2008 | 1034 | 0.010 |
Why?
|
| Gene Expression | 1 | 2017 | 7598 | 0.010 |
Why?
|
| Chromosomes, Human, 19-20 | 1 | 2003 | 11 | 0.010 |
Why?
|
| Mosaicism | 1 | 2007 | 480 | 0.010 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 2003 | 49 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2008 | 2000 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 2005 | 248 | 0.010 |
Why?
|
| Marijuana Abuse | 1 | 2008 | 409 | 0.010 |
Why?
|
| Tracheotomy | 1 | 2004 | 174 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2007 | 1375 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 2007 | 635 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 2076 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2008 | 2230 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 2005 | 447 | 0.010 |
Why?
|
| Incidence | 3 | 2008 | 21538 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2009 | 1474 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2008 | 2278 | 0.010 |
Why?
|
| Laryngectomy | 1 | 2004 | 245 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 183 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2479 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8748 | 0.010 |
Why?
|
| Homozygote | 1 | 2007 | 1779 | 0.010 |
Why?
|
| Time Factors | 2 | 2020 | 40218 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10760 | 0.010 |
Why?
|
| Age Distribution | 1 | 2008 | 2873 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2012 | 5403 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 4712 | 0.010 |
Why?
|
| Base Sequence | 1 | 2012 | 12421 | 0.010 |
Why?
|
| Cognition | 1 | 1999 | 7073 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9384 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2013 | 2185 | 0.010 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2000 | 12 | 0.010 |
Why?
|
| Reference Values | 1 | 2008 | 4938 | 0.010 |
Why?
|
| Neoplasms, Fibrous Tissue | 1 | 2000 | 19 | 0.010 |
Why?
|
| Reoperation | 1 | 2011 | 4329 | 0.010 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2000 | 68 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11669 | 0.010 |
Why?
|
| Meconium | 1 | 1999 | 47 | 0.010 |
Why?
|
| Movement | 1 | 2006 | 1490 | 0.010 |
Why?
|
| Laryngoscopy | 1 | 2004 | 714 | 0.010 |
Why?
|
| Disease Progression | 2 | 2007 | 13671 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2004 | 914 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7608 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1999 | 623 | 0.010 |
Why?
|
| Age of Onset | 1 | 2005 | 3347 | 0.010 |
Why?
|
| Linear Models | 1 | 2008 | 5884 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18349 | 0.010 |
Why?
|
| Macrolides | 1 | 1999 | 204 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 2176 | 0.010 |
Why?
|
| Benzamides | 1 | 2003 | 1379 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 16045 | 0.010 |
Why?
|
| Lymphatic System | 1 | 1999 | 251 | 0.010 |
Why?
|
| Alcoholism | 1 | 2008 | 1980 | 0.010 |
Why?
|
| Confusion | 1 | 1999 | 278 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1999 | 463 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13290 | 0.010 |
Why?
|
| Family | 1 | 2007 | 3209 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2000 | 483 | 0.010 |
Why?
|
| Collateral Circulation | 1 | 1997 | 291 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 2007 | 1932 | 0.010 |
Why?
|
| Arteriovenous Malformations | 1 | 1999 | 396 | 0.010 |
Why?
|
| Conversion Disorder | 1 | 1999 | 203 | 0.010 |
Why?
|
| Hypertension | 1 | 1995 | 8616 | 0.010 |
Why?
|
| Encephalitis | 1 | 1999 | 441 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 2000 | 905 | 0.010 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 1996 | 131 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 1627 | 0.010 |
Why?
|
| Cocaine | 1 | 1999 | 947 | 0.010 |
Why?
|
| Craniocerebral Trauma | 1 | 1999 | 493 | 0.010 |
Why?
|
| Anemia, Hemolytic | 1 | 1995 | 164 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2007 | 3591 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 1999 | 1015 | 0.010 |
Why?
|
| Angiography | 1 | 1999 | 1597 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 4063 | 0.010 |
Why?
|
| Algorithms | 2 | 2003 | 14164 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1995 | 677 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1997 | 1826 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 3729 | 0.010 |
Why?
|
| Survival Rate | 1 | 2006 | 12840 | 0.010 |
Why?
|
| Risk Factors | 3 | 2008 | 74944 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 1998 | 1189 | 0.010 |
Why?
|
| Aged | 1 | 2024 | 171504 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 9092 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2000 | 1885 | 0.010 |
Why?
|
| Artifacts | 1 | 1999 | 1926 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2003 | 3007 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 11095 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1999 | 5315 | 0.000 |
Why?
|
| Thrombocytopenia | 1 | 1995 | 1179 | 0.000 |
Why?
|
| Brain Concussion | 1 | 1999 | 1435 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1999 | 9669 | 0.000 |
Why?
|
| Length of Stay | 1 | 2001 | 6498 | 0.000 |
Why?
|
| Seizures | 1 | 1999 | 2998 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 59629 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1999 | 14783 | 0.000 |
Why?
|